Skip to content

Drug interactions

Influenza virus vaccine quadrivalent recombinant + Sirolimus

Severity: Minor

Influenza virus vaccine quadrivalent recombinant and Sirolimus: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Sirolimus-related immunosuppression may reduce the antibody response to the recombinant influenza vaccine. The vaccine is non-live and safe to give, but protection may be incomplete.

What this interaction means in plain words

Influenza virus vaccine quadrivalent recombinant and Sirolimus have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Moderate

Why it happens

Pharmacodynamic: mTOR inhibition dampens T- and B-cell responses to vaccination.

What to do

Vaccinate as recommended, ideally before transplant or at a time of lower immunosuppression; do not withhold the vaccine, and consider reinforcing protection through household immunization.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Influenza virus vaccine quadrivalent recombinant and Sirolimus, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Influenza virus vaccine quadrivalent recombinant with Sirolimus?

MediHelp rates the interaction as minor. Influenza virus vaccine quadrivalent recombinant and Sirolimus have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Sirolimus-related immunosuppression may reduce the antibody response to the recombinant influenza vaccine. The vaccine is non-live and safe to give, but protection may be incomplete.

How serious is the interaction between Influenza virus vaccine quadrivalent recombinant and Sirolimus?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Vaccinate as recommended, ideally before transplant or at a time of lower immunosuppression; do not withhold the vaccine, and consider reinforcing protection through household immunization.

What other medicines interact with Sirolimus?

MediHelp also lists interactions of Sirolimus with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Sirolimus page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in